UCL Department of Biochemical Engineering


Centre feasibility studies

Funding for post-doctoral feasibility studies of 6-12 months duration is available to UK academics external to the Centre. These studies need to relate to the Centre vision but can span the full breadth of our remit.  

These studies are encouraged to make use of Centre facilities and they should involve active collaboration with a Centre researcher.

The intention is that Centre involvement will help to bring these studies forward to a point where incorporation within the Centre programme is possible or where new funding opportunities are created. In this way these studies grow the capabilities of the Centre and its network of users.

The priority themes for feasibility studies are: Biophysical measurement New technologies and manufacturing strategies Modelling / Optimisation methodologies Life cycle cost analysis

  1. Biophysical measurement
  2. New technologies and manufacturing strategies
  3. Modelling / Optimisation methodologies
  4. Life cycle cost analysis


In addition, the Centre will periodically issue calls for proposals on specific topics through the Open Call pages on the EPSRC website.

Feasibility studies funded since 2011



Lead InvestigatorOrganisationTitleStart DateValue
Dr Jon SussexOffice of Health EconomicsMeasuring expenditure on research into manufacturingJune 2012£29,000
Dr Daryl WilliamsImperial College LondonProtein crystallisation of Monoclonal AntibodiesMay 2013£27,000
Dr Oliver HardickUniversity College LondonProduction and derivatisation of nanofibre adsorbents for high productivity purificationMarch 2013£20,000
Prof. Mire ZlohUniversity of HertfordshireMolecular dynamics simulation of freeze drying processes: effects of excipients on protein structure and stability during freezing processesApril 2013£4,000
Dr Stephanie AllenUniversity of NottinghamMolecular Force Based Assays for the Prediction of Stability and Performance of Lyophilized Biopharmaceutical FormulationsApril 2013£20,000
Prof Alexander 'Sasha' GolovanovUniversity of ManchesterProtein biopharmaceuticals as NMR targetsMarch 2013



Dr Jonathan HuddlestonBrunel UniversityAnalytical Aqueous Phase Partitioning (AAPP) for the Biophysical Characterisation of Protein Isoforms/ adenovirus, liquid-liquid technology, scalabilityLate 2013£30,000